Tag: Moderna Inc.
-
Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise
[ad_1] A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%, the drug makers said Sunday. About 79% of melanoma patients in a 157-person trial who were treated with Moderna’s personalized mRNA-4157 (V940) therapy in combination with…